BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21563990)

  • 1. Robustness testing in pharmaceutical freeze-drying: inter-relation of process conditions and product quality attributes studied for a vaccine formulation.
    Schneid SC; Stärtzel PM; Lettner P; Gieseler H
    Pharm Dev Technol; 2011; 16(6):583-90. PubMed ID: 21563990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved formulation and lyophilization cycle for rBCG vaccine.
    Jin TH; Nguyen L; Qu T; Tsao E
    Vaccine; 2011 Jun; 29(29-30):4848-52. PubMed ID: 21549782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of laboratory and production freeze drying cycles.
    Kuu WY; Hardwick LM; Akers MJ
    Int J Pharm; 2005 Sep; 302(1-2):56-67. PubMed ID: 16099610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
    Beirowski J; Inghelbrecht S; Arien A; Gieseler H
    J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collapse temperature of freeze-dried Lactobacillus bulgaricus suspensions and protective media.
    Fonseca F; Passot S; Cunin O; Marin M
    Biotechnol Prog; 2004; 20(1):229-38. PubMed ID: 14763847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyophilization cycle development for a high-concentration monoclonal antibody formulation lacking a crystalline bulking agent.
    Colandene JD; Maldonado LM; Creagh AT; Vrettos JS; Goad KG; Spitznagel TM
    J Pharm Sci; 2007 Jun; 96(6):1598-608. PubMed ID: 17117409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of polymorphic forms of ranitidine hydrochloride.
    Wu V; Rades T; Saville DJ
    Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of a pharmaceutical freeze-dried product and its process using an experimental design approach and innovative process analyzers.
    De Beer TR; Wiggenhorn M; Hawe A; Kasper JC; Almeida A; Quinten T; Friess W; Winter G; Vervaet C; Remon JP
    Talanta; 2011 Feb; 83(5):1623-33. PubMed ID: 21238761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low temperature properties of lyophilized solutions and their influence on lyophilization cycle design: pentamidine isethionate.
    Williams NA; Schwinke DL
    J Pharm Sci Technol; 1994; 48(3):135-9. PubMed ID: 8069514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Optical Coherence Tomography Freeze-Drying Microscopy for Designing Lyophilization Process and Its Impact on Process Efficiency and Product Quality.
    Korang-Yeboah M; Srinivasan C; Siddiqui A; Awotwe-Otoo D; Cruz CN; Muhammad A
    AAPS PharmSciTech; 2018 Jan; 19(1):448-459. PubMed ID: 28785859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyophilization cycle development for interleukin-2.
    Vemuri S
    Dev Biol Stand; 1992; 74():341-51. PubMed ID: 1592183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles.
    Kuu WY; Hardwick LM; Akers MJ
    Int J Pharm; 2006 Apr; 313(1-2):99-113. PubMed ID: 16513303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural attributes of model protein formulations prepared by rapid freeze-drying cycles in a microscale heating stage.
    Peters BH; Molnár F; Ketolainen J
    Eur J Pharm Biopharm; 2014 Jul; 87(2):347-56. PubMed ID: 24607807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein purification process engineering. Freeze drying: A practical overview.
    Gatlin LA; Nail SL
    Bioprocess Technol; 1994; 18():317-67. PubMed ID: 7764173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of primary drying temperature on process efficiency and product performance of lyophilized Ertapenam sodium.
    Vohra ZA; Zode SS; Bansal AK
    Drug Dev Ind Pharm; 2019 Dec; 45(12):1940-1948. PubMed ID: 31625418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage.
    Abdelwahed W; Degobert G; Fessi H
    Eur J Pharm Biopharm; 2006 Jun; 63(2):87-94. PubMed ID: 16621490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calorimetry and complementary techniques to characterize frozen and freeze-dried systems.
    Sundaramurthi P; Suryanarayanan R
    Adv Drug Deliv Rev; 2012 Apr; 64(5):384-95. PubMed ID: 22210136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Well-plate freeze-drying: a high throughput platform for screening of physical properties of freeze-dried formulations.
    Trnka H; Rantanen J; Grohganz H
    Pharm Dev Technol; 2015 Jan; 20(1):65-73. PubMed ID: 24417680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the sucrose/glycine/water system by differential scanning calorimetry and freeze-drying microscopy.
    Kasraian K; Spitznagel TM; Juneau JA; Yim K
    Pharm Dev Technol; 1998 May; 3(2):233-9. PubMed ID: 9653761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.